Cell-Free Microfluidic Peptide Screening for GPCR Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing droplet-based microfluidic systems for high-throughput screening of peptide compounds face limitations in loading diverse compounds and monitoring interactions with target receptors, leading to slow throughput and inability to efficiently screen large libraries.

Innovation Solution

A process involving the formation of water-in-oil droplets containing plasmids encoding peptides, which are replicated and expressed using rolling circle amplification and in vitro transcription/translation, then merged with droplets containing G protein-coupled receptors, and sorted based on signal emission to identify active peptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If droplet-based microfluidics is used for high-throughput screening, then the number of screened units increases and sample consumption decreases, but the ability to load diverse candidate compounds and monitor interactions with target receptors is limited

Engineering Contradiction:
Improvethroughput of screeningVSAvoidability to load diverse compounds and monitor interactions
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The screening process is divided into distinct functional modules: droplet generation with plasmid encapsulation, rolling circle amplification zone, in vitro transcription-translation zone, and detection zone. Each module performs a specific function, allowing the system to maintain high throughput while accommodating complex multi-step biochemical processes for diverse peptide screening

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfluidic device is designed to universally handle diverse plasmid libraries encoding different peptide candidates using the same rolling circle amplification and in vitro expression system. The system can screen any peptide that interacts with the target receptor through the unified detection methodology, making it adaptable to various therapeutic candidates

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If manual loading of candidate compounds is used, then compound diversity can be accommodated, but the loading speed becomes very slow compared to droplet production rate

Engineering Contradiction:
Improvecompound diversityVSAvoidloading speed
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

Candidate peptides are pre-encoded in plasmid libraries before the screening process. This preliminary encoding allows thousands of diverse compounds to be prepared in advance in a single tube, eliminating the need for slow individual loading during the screening process while maintaining full compound diversity

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The plasmid library serves as a master copy containing all candidate peptide sequences. Through rolling circle amplification, each plasmid is replicated to generate multiple copies within droplets, enabling high-throughput screening of diverse compounds without manual loading. The genetic code acts as a reproducible template that can be rapidly copied

Inventive Principle:
Principle #26Copying

3Productivity

If traditional high-throughput screening in microtiter plates is used, then automation and throughput can be achieved, but reagent and material consumption increases

Engineering Contradiction:
Improvethroughput of screeningVSAvoidreagent and material consumption
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The system uses microfluidic hydrodynamics to generate and manipulate picoliter-scale droplets. This hydraulic approach enables precise reagent delivery and mixing at ultra-low volumes, achieving high throughput screening with minimal reagent consumption compared to microliter-scale microtiter plate assays

Inventive Principle:
Principle #29Pneumatics and hydraulics

Solution Approach 2:

The system transitions from microliter-scale reactions in microtiter plates to picoliter-scale reactions in droplets. This parameter change in volume scale maintains the same throughput capability while reducing reagent consumption by a factor of 1000, as each droplet requires proportionally less reagent while still enabling detection

Inventive Principle:
Principle #35Parameter changes

4Productivity

If rolling circle amplification and in vitro transcription-translation are performed in droplets, then peptide expression can be achieved, but precise control during picoinjection is required to deliver the right amount of reagents

Engineering Contradiction:
Improvepeptide expression efficiencyVSAvoidcontrol precision during picoinjection
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The microfluidic device merges multiple reagent streams (polymerase, nucleotides, transcription-translation mix) with plasmid-containing droplets in a controlled manner. This merging approach delivers all necessary reagents in precise stoichiometric ratios directly into each droplet, eliminating the need for complex sequential picoinjection while maintaining expression efficiency

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The droplet interface acts as an intermediary that pre-organizes plasmids and protects them until the appropriate zone. Reagents are delivered through controlled mixing zones where the droplet membrane facilitates selective permeation and mixing, simplifying the control of reagent delivery compared to direct picoinjection into isolated droplets

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high-throughput screening of peptide libraries by efficiently identifying peptides that activate G protein-coupled receptors, allowing for rapid discovery of therapeutic candidates.

Implementation Method 1

a polymerase capable of rolling circle replication of plasmids, replicating the plasmids using the polymerase capable of rolling circle replication of plasmids

Methodology Applied
Scientific EffectRolling circle replication:

Implementation Method 2

an in vitro transcription/translation system, expressing the candidate peptides or pro-peptides encoded thereon using the in vitro transcription/translation system

Methodology Applied
Scientific EffectTranscription:

Implementation Method 3

an in vitro transcription/translation system, expressing the candidate peptides or pro-peptides encoded thereon using the in vitro transcription/translation system

Methodology Applied
Scientific EffectTranslation:

Implementation Method 4

If hydrolysed, the fluorogenic casein substrate, emitted a fluorescent signal that was used to sort the droplets

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 5

a G protein-coupled receptor has a reporter moiety coupled to it and said reporter moiety is capable of emitting a signal, preferably an electromagnetic radiation signal, upon functional activation of the G protein-coupled receptor

Methodology Applied
Scientific EffectSignal emission:

Data Source

PatentEP4617661A1Cell-free expression and screening microfluidic platform for peptide drug discovery
Publication Date: 2025.09.17 ETH ZURICH
  • EP4617661A1 patent drawingFigure 1~1B
  • EP4617661A1 patent drawingFigure 2~2C
  • EP4617661A1 patent drawingFigure 3~3B

AI summary

A process for screening a plasmid library encoding for peptides for one or more peptides that functionally activate a G protein-coupled receptor in a cell, by contacting the peptides with a cell expressing a G protein-coupled receptor, which functions as a sensor, and isolating the cells that functionally activate a G protein-coupled receptor to determine the sequence encoding the peptides.